Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Paragon Care's Total Liabilities for the quarter that ended in Jun. 2026 was A$1,077 Mil. Paragon Care's Total Assets for the quarter that ended in Jun. 2026 was A$1,373 Mil.
Therefore, Paragon Care's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2026 was 0.79.
Paragon Care (ASX:PGC) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Paragon Care Liabilities-to-Assets Related Terms
Paragon Care Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for Paragon Care's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PGC vs MCK, COR, CAH: Liabilities-to-Assets Comparison
For the Medical Distribution subindustry, Paragon Care's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care Liabilities-to-Assets vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Paragon Care's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Paragon Care's Liabilities-to-Assets Ratio for the fiscal year that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon Care (ASX:PGC) has a Liabilities-to-Assets of 0.79 as of Jun. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Paragon Care and its competitors.
Is Paragon Care's Liabilities-to-Assets too high?
Paragon Care's current Liabilities-to-Assets is 0.79. Overall, Paragon Care has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's Liabilities-to-Assets compare to MCK and COR?
Paragon Care's Liabilities-to-Assets of 0.79 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Medical Distribution company?
A good Liabilities-to-Assets depends on the Medical Distribution industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Paragon Care and its competitors. Paragon Care's current Liabilities-to-Assets is 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (ASX:PGC) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.33, compared to a current price of A$0.14 — trading 59.1% below its estimated fair value. The current Liabilities-to-Assets is 0.79. Paragon Care's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Paragon Care (ASX:PGC), the current Liabilities-to-Assets is 0.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (ASX:PGC) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of A$0.14 is trading 59.1% below its estimated GF Value™ of A$0.33.
GuruFocus considers Paragon Care to be Significantly Undervalued.
Key valuation signals for ASX:PGC:
Liabilities-to-Assets: 0.79
GF Value™: A$0.33 vs. price of A$0.14 (59.1% below fair value)
No single metric tells the full story. See the ASX:PGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
60GF Score
Get the complete analysis for ASX:PGC
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PGC has been successfully added to your 
